Navigation Links
ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis
Date:12/16/2009

information, please refer to www.chemocentryx.com.

Any statements in this press release about ChemoCentryx's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as may, believe, will, expect, anticipate, estimate, intend, predict, seek, potential, continue, plan, should, could and would or the negative of these terms or other comparable terminology. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to (i) the initiation, timing, progress and results of ChemoCentryx's preclinical studies and clinical trials, (ii) ChemoCentryx's ability to advance product candidates into clinical trials, (iii) GSK's exercise of its license options, (iv) the commercialization of ChemoCentryx's product candidates, (v) the implementation of ChemoCentryx's business model, strategic plans for its business, product candidates and technology, (vi) ChemoCentryx's ability to maintain and establish collaborations or obtain additional government grant funding, (vii) ChemoCentryx's estimates of its expenses, future revenues, capital requirements and its needs for additional financing, (vii
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Maintaining Remission in Patients with Crohns Disease
2. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
3. PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryxs Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
4. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
5. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
6. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
7. Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimers Disease
8. Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients
9. Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients
10. Incept BioSystems Initiates First Human Clinical Trial of its SMART Embryo Culture System for In Vitro Fertilization (IVF)
11. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... N.C. , May 17, 2013  Technology ... organizations communicate internally. Faced with a constantly evolving ... strategies and tactics for communicating with internal executives. ... of all the strategies, tactics and tools that ... In a new study, Best Practices, LLC ...
(Date:5/17/2013)... PHILADELPHIA , May 17, 2013 ... disorders; health economics and outcomes research also   to ... SHP, NASDAQ: SHPG ), the global specialty ... in 7 poster presentations at the American Psychiatric Association ... , May 18-22. The data being presented represent ...
(Date:5/17/2013)... LAKES, Fla. , May 17, 2013 Fuse ... and delivery technology company that is developing new, patent-pending technologies ... minerals, announced today that it will hold a business update ... Wednesday, May 22 nd , 2013 at 4:30 PM ET. ... Tuffin will host the call and will be ...
Breaking Medicine Technology:Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2
(Date:5/18/2013)... (PRWEB) May 18, 2013 The Ayurvedic ... ayurvedic education institution in the West. Program is available ... , Ayurveda is a healing modality practiced for over ... it is considered that health begins when an individual ... understanding of their individual needs. Ayurveda aims to heal ...
(Date:5/18/2013)... Morro Bay, CA (PRWEB) May 18, 2013 ... salon , has recently completed a stylish renovation that ... and advanced specialties. , From the ground up, this ... been improved with fresh flooring, soothing colors and comfortable ... have been installed, including an Apilus epilator machine. ...
(Date:5/18/2013)... 2013 Losing weight remains to be the ... horde of new weight loss products available in the market ... studies about this newest weight loss supplement prove that dieting ... , Garcinia Cambogia is a sub-tropical fruit that is shaped ... fruit can suppress a person’s appetite, while it effectively burns ...
(Date:5/18/2013)... May 18, 2013 Spectrum Surgical ... on May 17-22 in Austin, TX where thousands ... educational and networking opportunities. , Spectrum Surgical/STERIS ... flexible scope repair capabilities and certified pre-owned ... educational information on proper instrument care of flexible ...
(Date:5/18/2013)... 2013 The topics that will be covered ... scrum roles, scrum meetings, scrum artifacts, and scrum simulation (optional). ... attending them. , These trainings are suitable for business analysts, ... for those who will be a part of the Scrum ... to explore Agile and Scrum, but are unsure of what ...
Breaking Medicine News(10 mins):Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3
... Bicuspid Aortic Valve (BAV), a condition in which patients, aortic valves ... most common cardiac anomaly, affecting up to two percent of the ... the heart valve, leakage of the valve and may results in ... of breath. The condition is easily diagnosed; often physicians can ...
... New research from Jefferson Hospital for Neuroscience ... (CIDP) is diagnosed. Eduardo De Sousa, M.D., ... of Thomas Jefferson University, and director of the ... which looked at the number of demyelinating features ...
... Pharma Global Development ("APGD"), a subsidiary of Astellas Pharma ... Peter Carberry, has been hired as the senior vice ... responsible for enhancing the effectiveness and efficiency of the ... clinical operations organizations. , , "We are pleased ...
... , Microsoft,s ,Browser for the Better, campaign donates equivalent of ... , , REDMOND, Wash., June 10 More than ... breakfast and lunch at their local public schools; as schools ... programs. In response, Microsoft Corp. and Feeding America are joining ...
... Vacation Spots Place Visitors at Risk for Increased UV Exposure ... travelers and their families head off to their favorite vacation ... for increased exposure to the sun,s dangerous ultraviolet (UV) rays. ... beaches and islands in warmer climates, are spots that have ...
... Rationing-by-Bureaucrat Proposal an Outrage to Older Americans , , ... RetireSafe blasted President Obama and his Congressional allies for proposing ... for "health care reform." Thair Phillips, the new president ... American." , , Said Phillips, "I,m outraged that ...
Cached Medicine News:Health News:First-degree relatives of patients with bicuspid aortic valve should be screened 2Health News:New Jefferson study may redefine how a chronic auto-immune disease is diagnosed 2Health News:Astellas Names Head of Global R&D Operations 2Health News:Microsoft and Feeding America Join Forces to Fight Hunger 2Health News:Microsoft and Feeding America Join Forces to Fight Hunger 3Health News:Summer Travel Destinations are Heavy on Fun - and Sun 2Health News:Summer Travel Destinations are Heavy on Fun - and Sun 3Health News:RetireSafe Blasts Plan to Pay for Health Care Reform With Huge Medicare Cuts 2
The pediatric blanket provides full coverage for pediatric patient care. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also red...
The under-patient design of the pediatric full access blanket warms even the tiniest patients while allowing full access for surgeons and staff....
2-ply material consisting of polyethylene film inner layer and non-woven outer layers. Polyethylene cover....
The new Cardiac ThermoWrap provides precise and continuous management of body temperature, thermally protecting your patient in this exceedingly complex environment....
Medicine Products: